Who Owns CAMP4 Therapeutics Stock?
NASDAQ: CAMPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 84.60%
- Held by insiders
- 9.04%
- Institutional holders
- 95
- Institutions 84.6%
- Insiders 9.0%
- Public and other 6.4%
Who owns CAMP4 Therapeutics stock?
Institutional investors own about 84.6% of CAMP4 Therapeutics's shares, spread across 95 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 9.04% of CAMP.
The largest institutional holders are Janus Henderson Group Ltd. (12.41%), Vivo Capital, LLC (8.90%) and 5AM Venture Management, LLC (8.41%). Together, the top 10 institutions control 65.1% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their CAMP positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of CAMP
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Janus Henderson Group Ltd. | 7.79M | 12.41% | +23.5% |
| Vivo Capital, LLC | 5.58M | 8.90% | +31.5% |
| 5AM Venture Management, LLC | 5.28M | 8.41% | -10.1% |
| FMR, LLC | 4.91M | 7.82% | +0.1% |
| Adage Capital Partners GP L.L.C. | 4.19M | 6.68% | +113.7% |
| Trails Edge Capital Partners, LP | 3.63M | 5.78% | +87.6% |
| Stonepine Capital Management, LLC | 2.79M | 4.44% | +100.5% |
| Balyasny Asset Management LP | 2.41M | 3.84% | -6.4% |
| Vanguard Capital Management LLC | 2.15M | 3.42% | +40.0% |
| a16z Capital Management, L.L.C. | 2.13M | 3.39% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of CAMP
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 1.34M | 2.14% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.14M | 1.82% |
| iShares Trust-iShares Russell 2000 ETF | 717.98K | 1.14% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 399.58K | 0.64% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 357.19K | 0.57% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 345.79K | 0.55% |
| iShares Trust-iShares Russell 2000 Growth ETF | 299.76K | 0.48% |
| Victory Portfolios III-Victory Science & Technology Fund | 226.60K | 0.36% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 213.65K | 0.34% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 180.30K | 0.29% |
Frequently asked questions
Who is the largest shareholder of CAMP4 Therapeutics?
Janus Henderson Group Ltd. is the largest institutional shareholder of CAMP, owning 12.41% of shares outstanding (7.79M shares) as of its latest 13F filing.
What percentage of CAMP4 Therapeutics is owned by institutions?
Institutions own about 84.6% of CAMP shares and 93.0% of the public float.
How much of CAMP4 Therapeutics do insiders own?
Insiders, such as officers and directors, own about 9.04% of CAMP shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.